CRL EPS Estimates
Charles River Laboratories International, Inc.
$337.52
+$24.50(+7.83%)
66
Overall
60
Value
83
Tech
57
Quality
Market Cap
$15.00B
Volume
982.92K
52W Range
$146.20 - $379.63
Target Price
$320.93
CRL EPS estimates: the consensus estimate for Charles River Laboratories International, Inc.'s current fiscal year is $11.38 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRL EPS Estimates
- EPS estimate, current quarter
- $2.98
- EPS estimate, next quarter
- $3.30
- EPS estimate, current year
- $11.38
- EPS estimate, next year
- $12.75
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.91 |
| 2024 | $0.20 |
| 2023 | $9.27 |
| 2022 | $9.57 |
| 2021 | $7.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRL | $337.52 | +7.8% | 982.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Charles River Laboratories International, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW